RichFakirNSE · BSEOpen live analysis →

Sangal Papers Ltd

516096.BO · Commodities

Sangal Papers manufactures various grades of paper including newsprint, writing, printing, and specialty colored papers using 100% recycled waste paper. It serves both domestic and international markets, primarily selling to dealers and industrial customers for packaging and educational use.

Our view
Not rated
Quality score
36
Discount to fair value
+12%
See the full interactive analysis — quality radar, 12-year financials & more →
Fair value / share
₹216
Discount to fair value
+12%
Quality score
36/100
Return on equity
7.8%
Revenue growth (5y)
3.1%
P/E
5.8

Competitive advantage

The company operates in a highly fragmented, commodity-driven industry with no evidence of brand power or cost advantage, as reflected in thin net margins of 1.7%. While they claim a specialty in color paper, the low ROCE of 10% suggests they lack the pricing power or scale to earn returns significantly above their cost of capital.

Capital allocation

Capital is primarily deployed toward routine plant modernization and maintenance CAPEX to remain competitive in a low-margin industry. The company has avoided dividends to reinvest in growth, yet revenue CAGR of 3.1% suggests this reinvestment is barely keeping pace with inflation rather than driving significant expansion.

Bear case

Five years out, the business succumbed to the 'commodity treadmill' where reinvestment barely matched inflation. The thin 1.7% margins were obliterated by a cyclical spike in raw material costs and energy prices, which the company could not pass on due to lack of pricing power. As export markets continued to wither, the stagnant 3.1% revenue growth turned negative, and the interest coverage—already a mediocre 2.5—collapsed under the weight of debt used for 'modernization' that failed to yield superior returns. The pledged promoter shares were eventually triggered during a liquidity crunch, leading to a loss of control and a permanent impairment of capital for minority shareholders.

Questions & answers

Is Sangal Papers Ltd (516096.BO) a good business?

RichFakir rates Sangal Papers Ltd's business quality as poor — 36/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.

Is Sangal Papers Ltd overvalued or undervalued?

On our model, Sangal Papers Ltd is trading about 12% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.

What is RichFakir's verdict on Sangal Papers Ltd (516096.BO)?

RichFakir's educational verdict on Sangal Papers Ltd is: Not rated. A poor business at a fair price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.

What is Sangal Papers Ltd's fair value?

RichFakir's educational estimate of Sangal Papers Ltd's fair value is about ₹216 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.

View the full live analysis →

Other companies

HORIZONINDSAHASRASYNOPTICS539983.BO540405.BO500166.BOPRIMECAB542721.BOBANG531810.BOHALDER506640.BO
RichFakir is an educational research tool, not investment advice. Figures are estimates from public filings and may contain errors. Do your own research.